BUSINESSDAILY MAIL
Windfall for Dragons' Den star as Perfectil maker Vitabiotics sold to US predator Bain for £900m
Vitabiotics, the maker of Perfectil, was sold to US-based Bain Capital for £900 million, resulting in a windfall for a Dragons' Den star. The acquisition marks a significant financial gain for the UK health and beauty company's stakeholders.
Related Signal
Adjacent reporting
- Dragons' Den star is set to sell Vitabiotics multivitamin firm backed by Tess Daly and Davina McCall for £900million
- Britain for sale: Ingredients firm Tate & Lyle is snapped up by US rival in £2.7billion deal
- How an AI windfall gave Bain Capital one of the most lucrative private equity deals ever
- Bayer sells stake in contraceptives business to Apollo in €3bn financing deal
- Unilever is exploring a bid for supplements maker Thorne in a potential $4 billion deal
- GSK to buy US cancer treatment firm Nuvalent for $10.6bn